An MD2-perturbing peptide has therapeutic effects in rodent and rhesus monkey models of stroke
Zongping Fang(Air Force Medical University), Lize Xiong(The Fourth People's Hospital), Jun‐Jun Kang(Air Force Medical University), Sijun Hu(Air Force Medical University), Yi Ding(Nankai University), Zhongmin Fan(Xijing Hospital), Jiao Deng(Tongji Hospital), Xunming Ji(Capital Medical University), Xijing Zhang(United Imaging Healthcare (China)), Siming Ning(Air Force Medical University), Qianzi Yang(Xijing Hospital), Shiquan Wang(Fuzhou University), Yingying Liu(Air Force Medical University), Jian Chen(Hong Kong University of Science and Technology), Di Wu(Capital Medical University), Wugang Hou(Xijing Hospital), Zhenhua Jiang(Xijing Hospital), Jinlin Miao(Xijing Hospital), Hailong Dong(Chinese Academy of Tropical Agricultural Sciences)
Cited by 50
Related Papers
Stroke in China: advances and challenges in epidemiology, prevention, and management
|The Lancet Neurology|2019|1.6k
Transfer of mitochondria from astrocytes to neurons after stroke
|Nature|2016|1.4k
Trial of Thrombectomy 6 to 24 Hours after Stroke Due to Basilar-Artery Occlusion
|New England Journal of Medicine|2022|707
Intubation and Ventilation amid the COVID-19 Outbreak
|Anesthesiology|2020|587
Caution on Kidney Dysfunctions of COVID-19 Patients
|medRxiv|2020|431